ciprofloxacin has been researched along with vx-770 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, DY; Lim, DJ; Mackey, C; McCormick, J; Skinner, D; Woodworth, BA; Zhang, S | 1 |
| Agarwal, S; Garg, V; Gebre, A; Han, L; Huang, J; Jiang, L; Lekstrom-Himes, J; Li, C; Robertson, S; Shen, J; Stephan, K; Wang, LT | 1 |
| Cho, DY; Garcia, JAP; Lim, DJ; Mackey, C; McCormick, J; Skinner, D; Weeks, CG; Woodworth, BA; Zhang, S | 1 |
| Allen, M; Cho, DY; Elder, JB; Grayson, JW; Lim, DJ; McCormick, J; McLemore, JG; Rowe, SM; Skinner, D; West, JM; Woodworth, BA; Zhang, S | 1 |
| Kabra, VD; Lahoti, SR | 1 |
1 trial(s) available for ciprofloxacin and vx-770
| Article | Year |
|---|---|
Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor.
Topics: Adolescent; Adult; Aminophenols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodioxoles; Ciprofloxacin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Indoles; Male; Middle Aged; Quinolones; Young Adult | 2019 |
4 other study(ies) available for ciprofloxacin and vx-770
| Article | Year |
|---|---|
Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa.
Topics: Aminophenols; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Synergism; Pseudomonas aeruginosa; Quinolones | 2019 |
In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.
Topics: Aminophenols; Anti-Bacterial Agents; Biofilms; Chloride Channel Agonists; Ciprofloxacin; Drug Liberation; Drug-Eluting Stents; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2019 |
Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.
Topics: Aminophenols; Animals; Chronic Disease; Ciprofloxacin; Maxillary Sinus; Pseudomonas; Pseudomonas Infections; Quinolones; Rabbits; Sinusitis; Stents | 2020 |
Novel therapeutic approach for the treatment of cystic fibrosis based on freeze-dried tridrug microparticles to treat cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Ciprofloxacin; Cystic Fibrosis; Dry Powder Inhalers; Humans; Particle Size | 2023 |